Literature DB >> 9020127

Three amino acid substitutions selectively disrupt the activation but not the repression function of the glucocorticoid receptor N terminus.

J A Iñiguez-Lluhí1, D Y Lou, K R Yamamoto.   

Abstract

A 210-amino acid region, termed enh2, near the N terminus of the rat glucocorticoid receptor, is necessary for both transcriptional activation and repression. The mechanism(s) of transcriptional regulation conferred by this region, however, are poorly understood. We screened in Saccharomyces cerevisiae a library of random mutants in the enh2 region of a constitutive glucocorticoid receptor derivative and isolated a series of multiply substituted receptors that are specifically defective in transcriptional activation. Although many substitutions in this area were tolerated, three amino acid substitutions (E219K, F220L, and W234R) within a 16-amino acid region were sufficient to disrupt the enh2 transcriptional activation function both in yeast and in mammalian cells. Although this region is rich in acidic residues, the conserved tryptophan at position 234 appears to be a more critical feature for enh2 activity; hydrophobic but not charged residues were tolerated at this position. Notably, the mutants uncoupled the activation and repression functions of enh2, as the activation defective isolates remained competent for repression of AP-1 at the composite response element plfG.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020127     DOI: 10.1074/jbc.272.7.4149

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor tau1 activation domain.

Authors:  A E Wallberg; K E Neely; A H Hassan; J A Gustafsson; J L Workman; A P Wright
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy.

Authors:  J A Iñiguez-Lluhí; D Pearce
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

3.  Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor.

Authors:  D Knutti; D Kressler; A Kralli
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

4.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy.

Authors:  Sam Holmstrom; Mary E Van Antwerp; Jorge A Iñiguez-Lluhi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

5.  Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2.

Authors:  Theodora E Danciu; Sergey Chupreta; Osvaldo Cruz; Jennifer E Fox; Malcolm Whitman; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

Review 6.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

7.  Hormone binding and co-regulator binding to the glucocorticoid receptor are allosterically coupled.

Authors:  Samuel J Pfaff; Robert J Fletterick
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

8.  Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor.

Authors:  M I Diamond; M R Robinson; K R Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 9.  Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

Authors:  Derek N Lavery; Iain J McEwan
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

10.  Activation of nuclear receptor coactivator PGC-1alpha by arginine methylation.

Authors:  Catherine Teyssier; Han Ma; Roger Emter; Anastasia Kralli; Michael R Stallcup
Journal:  Genes Dev       Date:  2005-06-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.